Influence of neutralizing antibodies to adalimumab and infliximab on the treatment of psoriasis

Abstract

Two biologics, adalimumab and infliximab, showed different therapeutic behaviour. The measurement of ADAs and drug concentrations has important implications for treatment with biologics.